|
Volumn 137, Issue 6, 2018, Pages 546-548
|
Global Impact of 2017 American College of Cardiology/American Heart Association Hypertension Guidelines: A Perspective from China
|
Author keywords
blood pressure; diagnosis; guideline; hypertension; therapeutics
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
GENERIC DRUG;
PLACEBO;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE MONITORING;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHINA;
COST CONTROL;
DIASTOLIC BLOOD PRESSURE;
EARLY INTERVENTION;
HUMAN;
HYPERTENSION;
MEDICAL DECISION MAKING;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
RISK ASSESSMENT;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
UNITED STATES;
BLOOD PRESSURE;
CARDIOLOGY;
DRUG EFFECT;
GLOBAL HEALTH;
PATHOPHYSIOLOGY;
RISK FACTOR;
STANDARDS;
TIME FACTOR;
AMERICAN HEART ASSOCIATION;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CARDIOLOGY;
CHINA;
GLOBAL HEALTH;
HUMANS;
HYPERTENSION;
PRACTICE GUIDELINES AS TOPIC;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
|
EID: 85048385308
PISSN: 00097322
EISSN: 15244539
Source Type: Journal
DOI: 10.1161/CIRCULATIONAHA.117.032890 Document Type: Review |
Times cited : (69)
|
References (5)
|